Altered PVN-to-CA2 hippocampal oxytocin pathway and reduced number of oxytocin-receptor expressing astrocytes in heart failure rats.
astrocyte
cardiovascular
glia
hippocampus
hypothalamus
oxytocin
Journal
Journal of neuroendocrinology
ISSN: 1365-2826
Titre abrégé: J Neuroendocrinol
Pays: United States
ID NLM: 8913461
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
04
05
2022
received:
10
03
2022
accepted:
05
05
2022
pubmed:
4
6
2022
medline:
30
7
2022
entrez:
3
6
2022
Statut:
ppublish
Résumé
Oxytocinergic actions within the hippocampal CA2 are important for neuromodulation, memory processing and social recognition. However, the source of the OTergic innervation, the cellular targets expressing the OT receptors (OTRs) and whether the PVN-to-CA2 OTergic system is altered during heart failure (HF), a condition recently associated with cognitive and mood decline, remains unknown. Using immunohistochemistry along with retrograde monosynaptic tracing, RNAscope and a novel OTR-Cre rat line, we show that the PVN (but not the supraoptic nucleus) is an important source of OTergic innervation to the CA2. These OTergic fibers were found in many instances in close apposition to OTR expressing cells within the CA2. Interestingly, while only a small proportion of neurons were found to express OTRs (~15%), this expression was much more abundant in CA2 astrocytes (~40%), an even higher proportion that was recently reported for astrocytes in the central amygdala. Using an established ischemic rat heart failure (HF) model, we found that HF resulted in robust changes in the PVN-to-CA2 OTergic system, both at the source and target levels. Within the PVN, we found an increased OT immunoreactivity, along with a diminished OTR expression in PVN neurons. Within the CA2 of HF rats, we observed a blunted OTergic innervation, along with a diminished OTR expression, which appeared to be restricted to CA2 astrocytes. Taken together, our studies highlight astrocytes as key cellular targets mediating OTergic PVN inputs to the CA2 hippocampal region. Moreover, they provide the first evidence for an altered PVN-to-CA2 OTergic system in HF rats, which could potentially contribute to previously reported cognitive and mood impairments in this animal model.
Identifiants
pubmed: 35657290
doi: 10.1111/jne.13166
pmc: PMC9495289
mid: NIHMS1809299
doi:
Substances chimiques
Receptors, Oxytocin
0
Oxytocin
50-56-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13166Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL090948
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS094640
Pays : United States
Organisme : NINDS NIH HHS
ID : NIH NS094640
Pays : United States
Organisme : National Heart, Lung, and Blood Institute Grant
ID : NIH HL090948
Informations de copyright
© 2022 British Society for Neuroendocrinology.
Références
J Neurosci. 2018 Jan 31;38(5):1218-1231
pubmed: 29279308
Neuron. 2019 Jul 3;103(1):133-146.e8
pubmed: 31104950
Neuroscience. 2014 Jul 25;273:12-23
pubmed: 24814726
J Neuroendocrinol. 2017 Oct 12;:
pubmed: 29024187
Neuroscience. 2018 Jun 15;381:46-58
pubmed: 29684507
Cardiovasc Res. 2008 Sep 1;79(4):671-8
pubmed: 18469338
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10041-5
pubmed: 16785436
J Neurosci. 1996 Aug 15;16(16):5233-55
pubmed: 8756452
Science. 2005 Apr 8;308(5719):245-8
pubmed: 15821089
Nat Rev Neurosci. 2008 Mar;9(3):182-94
pubmed: 18270514
Front Behav Neurosci. 2013 Dec 11;7:195
pubmed: 24376405
Arch Neurol. 2007 Oct;64(10):1482-7
pubmed: 17923631
Brain Res. 1985 Oct 28;346(1):51-7
pubmed: 4052770
Sci Rep. 2019 Feb 14;9(1):2005
pubmed: 30765864
Mol Psychiatry. 2021 May 25;:
pubmed: 34035479
Neuron. 2017 Jul 19;95(2):368-384.e5
pubmed: 28669546
Neuron. 2012 Feb 9;73(3):553-66
pubmed: 22325206
Ann Indian Acad Neurol. 2012 Oct;15(4):239-46
pubmed: 23349586
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16096-101
pubmed: 16249339
Hypertension. 2014 Mar;63(3):572-9
pubmed: 24343120
PLoS One. 2019 Jul 11;14(7):e0219784
pubmed: 31295328
Nat Commun. 2017 Sep 14;8(1):537
pubmed: 28912554
STAR Protoc. 2022 Feb 10;3(1):101160
pubmed: 35199030
J Physiol. 2020 Jan;598(1):33-59
pubmed: 31671478
Hippocampus. 2019 May;29(5):451-457
pubmed: 28888031
Neuron. 2018 Nov 7;100(3):593-608.e3
pubmed: 30293821
Viruses. 2010 Sep;2(9):2134-2153
pubmed: 21994722
Genes Brain Behav. 2019 Jan;18(1):e12535
pubmed: 30378258
Nat Protoc. 2006;1(6):3166-73
pubmed: 17406580
Front Mol Neurosci. 2020 Mar 18;13:40
pubmed: 32256314
Behav Brain Res. 2021 Sep 24;414:113452
pubmed: 34274373
J Neurosci. 2009 Feb 18;29(7):2259-71
pubmed: 19228979
J Neuroendocrinol. 2020 Feb;32(2):e12821
pubmed: 31845417
Curr Top Behav Neurosci. 2018;35:31-53
pubmed: 28864972
J Neurosci. 2016 Feb 24;36(8):2517-35
pubmed: 26911697
Nature. 2013 Aug 22;500(7463):458-62
pubmed: 23913275
Nat Commun. 2017 Dec 8;8(1):2001
pubmed: 29222469
Annu Rev Neurosci. 2008;31:69-89
pubmed: 18284371
Physiol Rev. 2017 Oct 1;97(4):1619-1747
pubmed: 28954853
Neuron. 2018 Sep 5;99(5):887-904
pubmed: 30189208
Commun Biol. 2021 May 14;4(1):586
pubmed: 33990685
J Atheroscler Thromb. 2017 Sep 1;24(9):884-894
pubmed: 28757538
Biol Psychiatry. 2016 Feb 1;79(3):155-64
pubmed: 26001309
Neuroscience. 1988 Mar;24(3):937-66
pubmed: 3380308
J Neuroinflammation. 2020 Jul 23;17(1):221
pubmed: 32703230
Curr Biol. 2018 Apr 2;28(7):1066-1078.e6
pubmed: 29551417
Nat Neurosci. 2021 Apr;24(4):529-541
pubmed: 33589833
Transl Psychiatry. 2019 Oct 17;9(1):260
pubmed: 31624233
Prog Neurobiol. 2018 Dec;171:1-14
pubmed: 30359747
Front Cell Neurosci. 2019 May 07;13:178
pubmed: 31133808
Int J Mol Sci. 2021 Aug 06;22(16):
pubmed: 34445168
Hypertension. 2011 Sep;58(3):454-63
pubmed: 21825233
Nat Rev Neurosci. 2006 Feb;7(2):126-36
pubmed: 16429122
Neuron. 1999 Jun;23(2):209-26
pubmed: 10399928
Nat Rev Neurosci. 2000 Oct;1(1):41-50
pubmed: 11252767
Prog Neurobiol. 2009 Jun;88(2):127-51
pubmed: 19482229
Nature. 2015 Apr 23;520(7548):499-504
pubmed: 25874674
Nat Rev Neurosci. 2014 Oct;15(10):655-69
pubmed: 25234264
J Clin Invest. 2005 Mar;115(3):500-8
pubmed: 15765131
Front Neuroanat. 2020 Oct 19;14:559402
pubmed: 33192340
Nat Neurosci. 2020 Sep;23(9):1125-1137
pubmed: 32719563
Neuroimage. 2015 Jan 15;105:84-92
pubmed: 25462699
Circ Heart Fail. 2018 Mar;11(3):e004476
pubmed: 29523517
Brain Res. 1983 Aug 29;273(2):307-17
pubmed: 6311351
Ann Neurol. 2002 Mar;51(3):290-5
pubmed: 11891823
Neuron. 2016 Mar 16;89(6):1291-1304
pubmed: 26948889
Psychoneuroendocrinology. 2014 Jul;45:128-41
pubmed: 24845184
J Neuroendocrinol. 2019 Dec;31(12):e12808
pubmed: 31715034